INMB (inmunebio.com) Bozor qiymatining balans qiymatiga nisbati
INmune Bio, Inc. (INMB) Altsgeymer kasalligida neyron degeneratsiyasiga qarshi kurashish uchun noyob XPro preparatidan foydalangan holda TNF ingibitorlarini ishlab chiqishga ixtisoslashgan. Moliyaviy model hukumat tomonidan qo'llab-quvvatlanishga va yallig'lanish patologiyalarini davolashga tayanadi, indikator 1.86 ga teng. Kompaniyaning GURU.Markets jadvalida mavjud bo'lgan narx harakati zamonaviy laboratoriyalar va shartnoma asosida ishlab chiqarish maydonlarining ommaviy dori vositalarini ishlab chiqarishga tayyorligi bilan qo'llab-quvvatlanadi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_INMB_-_INmune-Bio-Inc._-_Market-Capitalization-to-Net-Assets "INMB INmune Bio Corporation Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
INmune Bio Inc (INMB) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:INmune Bio, Inc. - INMB
INmune Bio, Inc. (INMB) barqarorligini baholashda men bozor qiymatining buxgalteriya qiymatiga nisbatini tahlil qilaman. Ushbu koeffitsient joriy kotirovkalarni sof aktivlarning haqiqiy qiymati bilan solishtirib, bozor tebranishlarini filtrlaydi. Narxning buxgalteriya qiymatiga nisbati tendentsiyasini o'rganish orqali investor biznesning haddan tashqari qimmat baholanganlik darajasini aniqlashi mumkin. INmune Bio, Inc. (INMB) uchun ushbu ko'rsatkich yuqori R&D xarajatlari tufayli juda muhimdir. Sinovlarning muvaffaqiyatsiz tugash xavflari buxgalteriya qiymatini xavfsizlik uchun asosiy mezonga aylantiradi.
Asosiy raqobatchilar
argenx SE (ARGX) - Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati RIGL (Rigel Pharmaceuticals Inc)|ANAB: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Astria Therapeutics|ENGN (engene.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati RAPT|Kapitallashuvning sof aktivlarga nisbati Aerovate (JBIO)|Kapitallashuvning sof aktivlarga nisbati ACRS|Bozor kapitallashuvining balans qiymatiga nisbati KYTX (Kyverna Therapeutics, Inc)|TLSA - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati cabalettabio.com CABA|VTYX (Ventyx Biosciences, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Theratechnologies, Inc. (THTX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Avalo Therapeutics Inc. AVTX|Eledon Pharmaceuticals, Inc (ELDN) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati Agenus|Bozor qiymatining balans qiymatiga nisbati climbbio.com|ZURA (Zura Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ATYR (aTyr Pharma Inc)|ADAG: Bozor qiymatining balans qiymatiga nisbati|IMA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Shattuck Therapeutics (STTK)|EQ - Balans qiymatiga nisbatan bozor qiymati|connectbiopharm.com - Bozor kapitallashuvining balans qiymatiga nisbati|IMUX (Immunic) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Atara Biotherapeutics, Inc. (ATRA)|Kapitallashuvning balans qiymatiga nisbati InflaRx GmbH|Bozor kapitallashuvining balans qiymatiga nisbati XFOR (X4 Pharmaceuticals)|Kapitallashuvning sof aktivlarga nisbati adicetbio.com ACET|Kapitallashuvning sof aktivlarga nisbati CELU|Balans qiymatiga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC BRNS|Bozor kapitallashuvining balans qiymatiga nisbati KZR (Kezar Life Sciences, Inc)|SABS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Akari Therapeutics|ENLV (Enlivex Therapeutics Ltd.) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati QTTB|Kapitallashuvning sof aktivlarga nisbati GeoVax Labs|Bozor kapitallashuvining balans qiymatiga nisbati Edesa (EDSA)|Bozor qiymatining balans qiymatiga nisbati IBIO (iBio Corporation)|Carisma Therapeutics Inc. (CARM) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi xtlbio.com XTLB|Bozor kapitallashuvining balans qiymatiga nisbati Bolt Bio (BOLT)|HCWB - Balans qiymatiga nisbatan bozor qiymati|APVO: Bozor kapitallashuvining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor kapitallashuvining balans qiymatiga nisbati|ADTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GRI|Bozor qiymatining balans qiymatiga nisbati XRTX (XORTX Therapeutics)|Kapitallashuvning sof aktivlarga nisbati Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|INDP - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Scinai Immunotherapeutics (SCNI)|CALI - Balans qiymatiga nisbatan bozor qiymati|affimed.com - Bozor kapitallashuvining balans qiymatiga nisbati|ALLK (Allakos) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati HOOK|Kapitallashuvning sof aktivlarga nisbati IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com OCEA|Kapitallashuvning sof aktivlarga nisbati TCBP (TC BioPharm)|Third Harmonic Bio Inc. - Bozor kapitallashuvining balans qiymatiga nisbati